Biocon partners with Civica to enhance insulin aspart availability in the US
03/07/25, 4:43 AM
Location
Industry
biopharma
biotechnology
Type
partnership
Biocon has entered into a partnership with Civica to enhance the availability of insulin aspart in the US. The partnership aims to address the need for improved access to this essential medication in the US market.
Company Info
Location
bengaluru, karnataka, india
Additional Info
We are a global biopharmaceutical company with the belief that everyone, everywhere deserves access to affordable quality medicines. Kiran Mazumdar-Shaw appointed as member of the Court of Regents at the Royal College of Surgeons of Edinburgh
Related People

Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Ph
Ph • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more

Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Rh
Rh • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more